The effect of luseogliflozin on epicardial fat accumulation in obese patients with type 2 diabetes
Not Applicable
- Conditions
- Type 2 diabetes
- Registration Number
- JPRN-UMIN000019072
- Lead Sponsor
- kyo Medical and Dental University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who are taking SGLT2 inhibitors Patients with insulin treatment Patients with active infection, malignancy, severe liver or renal diseases Patients who are unable to figure out the consent due to dementia or impairment of consciousness Pregnant women, lactating woman, women who are planning to get pregnant Patients whose treatment for diabetes were changed 3 months prior to baseline evaluation
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The change of epicardial fat volume at 12 weeks
- Secondary Outcome Measures
Name Time Method